Blastomycosis is a serious and potentially fatal infection caused by the thermally dimorphic fungus Blastomyces dermatitidis . Polymerase chain reaction (PCR) assays targeting the BAD-1 virulence gene promoter have been developed to aid in the detection of the pathogen in clinical and environmental samples. However, little is known regarding the genetic diversity of B. dermatitidis and how this might affect the performance characteristics of these assays. We explored the genetic relatedness of 106 clinical and environmental isolates of B. dermatitidis using a previously described rDNA PCR restriction fragment length polymorphism (RFLP) assay. In addition, we looked for polymorphisms in the promoter region upstream of BAD-1 . RFLP analysis showed that all isolates fell into one of fi ve genotypic groups, designated A through E. Genotypic groups A and B predominated, comprising 50/106 (47.2%) and 51/106 (48.1%) of isolates, respectively. Three of 106 (2.8%) isolates were genotype C. Genotypes D and E represented novel genotypes and were each associated with single clinical isolates. PCR of the BAD-1 promoter revealed signifi cant size differences among amplifi cation products. Fifty-one of 106 isolates (50/50 RFLP genotypic group A and 1/51 genotypic group B) had amplicons of 663-bp, nearly twice the size of the expected product. Sequence analysis of amplifi cation products from 17 representative isolates revealed four haplotypes and showed that the size disparity was due to two large insertions. Because these insertions were present in a high percentage of isolates, the utility of the PCR assays for diagnostic purposes could be affected. However, the novel RFLP genotypes and multiple BAD-1 haplotypes may prove useful as markers in population genetic studies.
Introduction
Blastomycosis is a serious and potentially fatal infection due to the thermally dimorphic fungus Blastomyces dermatitidis . The organism exists as a mold at ambient temperatures in the environment, but transforms into a pathogenic much more diffi cult to isolate B. dermatitidis from environmental sources employing techniques that have ranged from animal inoculations to in vitro cultivation with a variety of selective and non-selective artifi cial media [ 4 -6 ] . Despite intense efforts, less than two dozen environmental isolates have been reported in the medical literature.
Recently, a group of investigators developed polymerase chain reaction (PCR) assays for B. dermatitidis with the goal of improving the sensitivity and specifi city of the organism's detection in paraffi n-embedded tissues [ 7 ] . This method was subsequently applied to identify the pathogen from natural soil samples [ 8 ] . Both studies used an identical primer pair targeting the putative promoter region of BAD-1 (referred to previously as WI-1), a gene which codes for an important adhesin molecule and virulence factor [ 9 ] . Because little is known about the extent of this organism's genetic diversity, we evaluated a panel of clinical and environmental strains according to a previously published rDNA PCR restriction fragment length polymorphism (RFLP) assay and looked for polymorphisms in the promoter region of BAD-1 . We observed two novel RFLP genotypic groups in addition to three genotypes which had been described previously [ 10 ] . Additionally, a high percentage of isolates had polymorphisms in the BAD-1 promoter when compared to an ATCC (American Type Culture Collection, Rockville, MD) reference strain. These polymorphisms could undermine the utility of the PCR assays for detection of B. dermatitidis for diagnostic purposes, but may prove useful for population genetic studies.
Materials and methods

B. dermatitidis strains
One hundred and six isolates of B. dermatitidis were evaluated in this study. These included clinical isolates from human ( n ϭ 75), feline ( n ϭ 3), canine ( n ϭ 8), and equine ( n ϭ 1) sources obtained between 2005 and 2008 from Marshfi eld Laboratories ( n ϭ 87), as well as clinical isolates from human ( n ϭ 6) and canine ( n ϭ 1, ATCC MYA-2585) [ 11 ] sources recovered between 2007 and 2008 from Aurora Health Care, Inc. ( n ϭ 7). In addition, an in vitro environmental isolate from Wisconsin (ATCC MYA-2586) [ 6 ] obtained in 1997 ( n ϭ 1), human clinical ( n ϭ 2) and environmental ( n ϭ 3) isolates from the Eagle River [ 5 ] and Tomorrow River [ 12 ] Wisconsin outbreaks in 1984 and 1985 were part of the studies. Finally, environmental isolates (recovery dates unknown) from Georgia [ 13 ] ( n ϭ 4), a human clinical isolate (isolation date unknown) from Africa ( n ϭ 1), and the ATCC strain 26199 deposited in 1970 completed the test isolates. All were identifi ed using standard methods which included conversion to the yeast form when incubated in Middlebrook 7H9 broth at 35°C [ 14 ] .
DNA extraction
B. dermatitidis DNA was extracted using the QIAamp DNA Mini Kit Tissue Protocol (QIAGEN, Valencia, CA), with the volumes of buffer ATL, proteinase K, buffer AL, and ethanol altered to 540 μl, 60 μl, 500 μl, and 400 μl, respectively. Samples were incubated overnight at 56°C and then split onto two spin columns and eluted with a total of 100 μl buffer AE.
rDNA PCR RFLP
Isolates were classifi ed into genotypic groups by a PCR RFLP assay for the rDNA repeat region as described previously [ 10 ] . Briefl y, DNA was amplifi ed with the Expand Long Template PCR System (Roche, Indianapolis, IN) with primers BD28S and NS2. The resulting ~5.5 kb product was purifi ed with the QIAQuick PCR Purifi cation Kit (QIAGEN) and digested with Dde I . The fragments were separated through a 1.5% (wt/vol) SeaKem LE agarose (Lonza, Rockland, ME) gel in TBE buffer for 6 h at 83 volts. Bands were visualized by ultraviolet transillumination after ethidium bromide staining using a Gel Doc 2000 (Bio-Rad Laboratories, Hercules, CA). DNA band patterns were analyzed with BioNumerics software (Applied Maths, Sint-Martens-Latem, Belgium) and matched for percentage similarities by the Dice method (1.5% interband tolerance). Dendrograms were generated using the unweighted pair-group method with arithmetic average (UPGMA) method [ 15 ] .
PCR amplifi cation, sequencing and analysis of the BAD-1 promoter
A 363-bp region of the BAD-1 promoter region was amplifi ed by PCR using HotStarTaq Master Mix Kit (QIAGEN) and the Blasto I and Blasto II (Blasto I/II) primers as described previously [ 7 ] . PCR products were analyzed by gel electrophoresis on a 1.5% NuSieve ® 3:1 agarose gel (Lonza) with 0.5 mg/l ethidium bromide and visualized using a Gel Doc 2000 (Bio-Rad Laboratories). PCR products were purifi ed using the QIAQuick PCR Purifi cation Kit (QIAGEN) with the elution volume altered to 10 μl. The purifi ed PCR product was sequenced using the BigDye Terminator v3.1 cycle Sequencing Kit (Applied Biosystems, Warrington, United Kingdom) according to the manufacturer's recommendations. Dye terminators were removed from each reaction using the DyeEx 2.0 Spin Kit (QIAGEN). The reactions were dried at 70°C for 30 min, resuspended in 10 μl Hi-Di formamide, and denatured at 95°C for 2 min. Sequencing was performed on automated DNA sequencer model 3130xl (Applied Biosystems). DNA sequences were aligned using Lasergene99 software (DNASTAR Inc, Madison, WI) based upon 4-fold coverage of the amplifi ed region. Confi rmation of sequence identity was performed using the Basic Local Alignment Search Tool (BLAST) program for database searches at the National Center for Biotechnology Information (NCBI) website [ 16 ] . DNA sequences were used to determine haplotypes for the sequenced region. Sequence data were imported into BioNumerics and the sequences aligned and analyzed using pairwise alignment and UPGMA analysis to produce dendrograms displaying sequence relatedness.
Results
Based on rDNA PCR RFLP analysis, each of the 106 B. dermatitidis isolates fell into one of fi ve genotypic groups designated A through E ( Fig. 1 ) . Three of the genotypic groups (A, n ϭ 50, B, n ϭ 51, and C, n ϭ 3) correspond to those published previously by McCullough et al . [ 10 ] . Additionally, two novel genotypes, D ( n ϭ 1) and E ( n ϭ 1) were observed. Forty-nine of the group A isolates were from Wisconsin and one from Africa. Fifty of the B isolates were from Wisconsin with the ATCC strain, the other B type. All group C isolates were from Georgia. The group D isolate was from the upper peninsula of Michigan, whereas the group E isolate was from Wisconsin. A dendrogram showing representative isolates from each genotypic group is shown in Fig. 1 .
An unexpected fi nding was that the observed size of the Blasto I/II PCR products varied signifi cantly between genotypic groups. All group C, D, and E isolates and 50 of 51 group B isolates had amplicons of the expected size of ~363-bp. However, 50 of 50 genotypic group A isolates and 1 of 51 genotypic group B isolates had amplicons of 663-bp ( Fig. 2 ) . Sequencing of the amplicons from 17 representative isolates (5 group A, 7 group B, 3 group C, 1 group D, and 1 group E) confi rmed the presence of the size polymorphism and revealed several additional smaller genetic changes among and within genotypic groups ( Fig. 3 A) . The larger amplicon size in the genotypic group A isolates and the single group B isolate was due to a 35-bp insertion after bp-1614 and a 251-bp insertion after bp-1668 (numbering based on the published BAD-1 (WI-1) gene sequence, Genbank accession U37772).
Based upon the sequence variation of the BAD-1 amplicon, four haplotypes were identifi ed. The ATCC strain 26199, which is genotypic group B, was the only strain in haplotype 1 (H1 
Discussion
Blastomycosis is an important mycosis of humans and other mammals because it is associated with signifi cant morbidity and mortality [ 1 ] . Unfavorable outcomes are more likely when there is overwhelming infection or a delay in diagnosis and initiation of therapy. Fortunately, the laboratory diagnosis of blastomycosis is usually Fig. 1 Dendrogram produced from the rDNA PCR RFLP band patterns of 17 isolates of Blastomyces dermatitidis. Representative isolates of each genotypic group are shown from 106 isolates typed using this schema.
in Wisconsin. Analysis of a large panel of isolates by PCR RFLP of the rDNA repeat region revealed that all isolates fell into one of fi ve genotypic groups. Three genotypic groups (A, B, and C) predominated and accounted for over 98% of the isolates. Groups D and E were interesting because they appear to represent novel genotypes but were uncommon in our panel of isolates. These specimens are fi rst passage clinical isolates and have not been repeatedly subcultured. Of note, nine of the 106 isolates in our study were also included in the previous study by McCullough et al . [ 10 ] . We assigned fi ve of the nine isolates to different genotypic groups than were reported previously. This disparity in assigning genotypes may be due to differences in the gel running conditions, type and concentration of agarose, band tolerance settings, the normalization of the gels between runs or from many generations of subculturing under varying conditions in several laboratories. To resolve the genotype assignment discrepancies, we repeated the PCR-RFLP on the 5 isolates and our results were reproducible.
A signifi cant fi nding of our study was that different genotypic groups of B. dermatitidis are associated with markedly different PCR amplicon sizes when using the Blasto I/II primer pair. Groups C, D, E, and all but one of the B group isolates had products of the expected size, ~363-bp. However, all group A isolates and a single group B isolate produced a 663-bp product, nearly twice the expected size. This size disparity was due to the presence of two large insertions. Therefore, awareness of this size polymorphism is important when using the Blasto I/II primers, especially when working in geographic areas like Wisconsin where group A strains comprise ~50% of isolates, or in regions where the genetic diversity of B. dermatitidis is simply unknown. Methods straightforward and can be accomplished by routine histology and conventional culture techniques [ 14 ] . However, there are instances where histologic sections show scant and/or atypical fungal elements and there is no unfi xed specimen available for culture confi rmation. For these cases the availability of molecular diagnostic assays, such as PCR, can be a valuable diagnostic tool. In addition, molecular detection assays hold great promise in helping to elucidate the ecology of B. dermatitidis [8 ] . To date, efforts to identify the ecologic niche by organism detection using in vivo and in vitro culture methods have been largely unsuccessful [ 17 ,18 ] . Therefore, most of our knowledge of the ecologic characteristics and distribution of the fungus is based on reported disease occurrence. A sensitive and specifi c PCR-based assay for the detection of B. dermatitidis from environmental samples could greatly enhance our understanding of factors modulating disease transmission dynamics in natural settings.
Bialek and colleagues have published a PCR assay for B. dermatitidis that targets a 363-bp fragment of DNA upstream from the BAD-1 virulence gene [ 7 ] . Initially considered to be a promoter region, subsequent deletion experiments suggest that the targeted gene segment has little or no infl uence on BAD-1 expression [ 19 ] . Nevertheless, the stated goal of their study was to develop a molecular diagnostic tool for detection of B. dermatitidis DNA in tissue from paraffi n-embedded blocks [ 7 ] . This methodology has subsequently been applied to detect B. dermatitidis from natural soil samples [ 8 ] . Both studies showed promising results, but neither included an evaluation of how genetic diversity might affect the performance characteristics of their assays. We explored this possibility as part of our ongoing studies of the genetic diversity of B. dermatitidis Fig. 2 The amplifi cation products from a subset of the Blastomyces dermatitidis isolates (with the rDNA PCR RFLP genotypic groups designated) using the BlastoI/II primers within BAD-1 (WI-1) putative promoter region [7] . Lanes 1,20: 100-bp molecular weight ladder; Lanes 2-18: amplifi cation products from individual B. dermatitidis isolates; Lane 19: PCR reagent negative control.
Four haplotype groups were identifi ed among the 17 strains selected for sequencing (H1-H4). These haplotypes do not strictly correspond to the rDNA PCR RFLP groups with the exception of RFLP group A, of which all 5 isolates sequenced were H4. The haplotypes identifi ed through sequencing of this region may prove useful as genetic markers in studies aimed at understanding the population genetics of B. dermatitidis . The lack of variation within the genotypic group A (H4) isolates may indicate an apparent lack or reduction in the gene-fl ow between genotypic group A with genotypic groups B, C, D and E. Genotypic group A isolates clustered together in both typing schema, whereas the B, C, D and E strains showed different relatedness to each other in the two genotyping approaches. Isolates from genotypic groups A, B, D and E were obtained primarily from Wisconsin and included human used in Bialek et al .'s study may have been unable to detect isolates containing the insertions for several reasons. First, sequences of more than 600 bp might be diffi cult to amplify from paraffi n embedded tissues due to degradation of DNA by formalin fi xation. Second, the inner forward primer (Blasto III) used for the nested PCR is disrupted by insertion A, which may result in the lack of an amplifi cation product. Additionally, for both studies amplifi cation of a larger product may not have occurred if the assay was not optimized with this in mind. This is of special concern for detection of B. dermatitidis from environmental samples, as were tested by Burgess and colleagues, because of the wide range of inhibitory factors inherent to soil samples that may complicate nucleic acid extraction and amplifi cation [ 20 ] .
In addition to the large insertions, several additional polymorphisms were observed upstream from BAD-1 . and veterinary clinical specimens from overlapping geographic regions. While genotypic group A (H4) isolates appear to be genetically dissimilar to the other groups, this does not appear to be a function of temporal or spatial isolation. Additional research is needed to determine if the genetic isolation of genotypic group A holds true by examining isolates from diverse geographic areas using more precise and informative genetic markers from across the fungal genome. This approach will be important to understand whether the lack of genetic isolation is the result of the reduced interfertility or rather a function of ecological niche partitioning in the environment.
